CCRP practice question 7 of 25
In accordance with ICH, which of the following is an acceptable protocol review frequency for an IRB?
Full set: 130 questionsDomain Institutional Review Board (IRB)/Independent Ethics Committee (IEC)/Research Ethics Board (REB)
The International Council for Harmonisation (ICH) Guideline for Good Clinical Practice (GCP) E6(R2) mandates the minimum frequency for the continuing review of ongoing clinical trials by an Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Section 3.1.4 specifies that the IRB/IEC must review ongoing trials at intervals appropriate to the level of risk, but at least once per year. This "at least annually" requirement establishes a 12-month interval as the standard maximum period between reviews to ensure the continued protection of human subjects' rights, safety, and well-being.
A. 6 months: While more frequent reviews are permissible and may be appropriate for high-risk studies, 12 months is the standard minimum frequency (maximum interval) explicitly required by ICH GCP.
C. 24 months: This interval exceeds the "at least once per year" mandate and is therefore non-compliant with ICH GCP guidelines for continuing review.
D. 36 months: This interval significantly exceeds the maximum allowable period of one year between reviews and is a clear violation of ICH GCP standards.
1. International Council for Harmonisation (ICH). (2016). Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Section 3.1.4, page 12. "The IRB/IEC should conduct continuing review of each ongoing trial at intervals appropriate to the degree of risk to human subjects, but at least once per year."
2. U.S. Food and Drug Administration (FDA). (2023). Code of Federal Regulations, Title 21, Part 56, Section 109 (21 CFR 56.109(f)). "An IRB shall conduct continuing review of research covered by these regulations at intervals appropriate to the degree of risk, but not less than once per year."
3. University of California, San Francisco (UCSF), Human Research Protection Program. IRB Continuing Review Guidance. "Federal regulations require that the IRB re-approve all non-exempt human research projects at least annually (unless the study qualifies for an exception)." This university guidance reflects the implementation of federal and international standards.
Keep practicing
Take the free CCRP practice test
Ten exam-style questions with answers and explanations, plus the exam facts and study guides.
More questions
Other CCRP practice questions
- Question 1The study coordinator for a new Phase III vaccine study is preparing documents for IRB/IE…
- Question 2In a completed multi-site Phase I drug study using remote EDC, who ensures the system com…
- Question 3Which of the following is an example of an additional protection required when conducting…
- Question 4A clinical investigator is planning to conduct a quality of life medical device study in …
- Question 5In accordance with the ICH GCP Guideline, prior to initiating a trial, which of the follo…
- Question 6According to the CFR and the ICH GCP Guideline, which of the following must be submitted …
